selected publications
- Systemic versus local regulation of vitamin D. Current opinion in nephrology and hypertension. 2026 Academic Article GET IT
- Response to the "Letter to the Editor: ''Prebiotic Administration to CKD Patients Modifies Their Microbiome and Metabolism''.". Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation. 2026 Article GET IT
- Ferric Carboxymaltose Increases Fracture Risk in Patients and Reduces Bone Formation in Mice with Iron Deficiency Anemia. Blood. 2026 Academic Article GET IT
- Cardiovascular Outcomes among New Users of GLP-1 Receptor Agonists Compared with DPP-4 Inhibitors and Sulfonylureas in Kidney Failure. Journal of the American Society of Nephrology : JASN. 2026 Academic Article GET IT
- Effect of Clazakizumab on Neutrophil-Lymphocyte Ratio in Patients Receiving Hemodialysis: Secondary Analysis of the POSIBIL6ESKD Phase 2b Trial. Clinical journal of the American Society of Nephrology : CJASN. 2026 Academic Article GET IT
-
Fibroblast Growth Factor 23 Trajectories in Children and Association with CKD Progression: The CKD in Children Study.
Clinical journal of the American Society of Nephrology : CJASN.
2026
Academic Article
GET IT
Times cited: 1 -
Prebiotic Administration to Chronic Kidney Disease Patients Modifies Their Fecal Microbiome and Host Metabolism.
Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation.
2025
Academic Article
GET IT
Times cited: 3 - The authors reply. Kidney international. 2025 Article GET IT
-
Higher versus Lower Phosphate Targets for Patients Undergoing In-Center Hemodialysis: A Randomized Controlled Trial.
Journal of the American Society of Nephrology : JASN.
2025
Academic Article
GET IT
Times cited: 3 -
Effects of Lowering Dietary Phosphorus Additive Intake on Mineral Metabolism in Adults with and without CKD.
Clinical journal of the American Society of Nephrology : CJASN.
2025
Academic Article
GET IT
Times cited: 3 - Clinical evidence for independent regulation of vitamin D by intestinal CYP24A1. Reply. The Journal of clinical investigation. 2025 Academic Article GET IT
- Cultivating Innovative, Pragmatic, Randomized Controlled Registry Trials Embedded in Hemodialysis Care: Conference Proceeding From Gardener's Grove 2023. Canadian journal of kidney health and disease. 2025 Academic Article GET IT
-
Fibroblast growth factor 23 and fibroblast growth factor receptor 4 promote cardiac metabolic remodeling in chronic kidney disease.
Kidney international.
2025
Academic Article
GET IT
Times cited: 22 -
Effects of Clazakizumab on Anemia and Iron Metabolism in Patients with Kidney Failure.
Journal of the American Society of Nephrology : JASN.
2025
Academic Article
GET IT
Times cited: 2 -
Intravenous Iron Associated Hypophosphatemia: Much More Than a Laboratory Curiosity.
American journal of hematology.
2025
Academic Article
GET IT
Times cited: 3 -
Intestinal Cyp24a1 regulates vitamin D locally independent of systemic regulation by renal Cyp24a1 in mice.
The Journal of clinical investigation.
2024
Academic Article
GET IT
Times cited: 19 - Short and long-term effects of kidney donation on mineral and bone metabolism. BMC nephrology. 2024 Academic Article GET IT
-
Author Correction: IL-6 inhibition with clazakizumab in patients receiving maintenance dialysis: a randomized phase 2b trial.
Nature medicine.
2024
Article
GET IT
Times cited: 3 -
Design and Rationale of the Phase 2 Baricitinib Study in Apolipoprotein L1-Mediated Kidney Disease (JUSTICE).
Kidney international reports.
2024
Academic Article
GET IT
Times cited: 10 -
IL-6 inhibition with clazakizumab in patients receiving maintenance dialysis: a randomized phase 2b trial.
Nature medicine.
2024
Academic Article
GET IT
Times cited: 64 -
Risk factors for hip and vertebral fractures in chronic kidney disease: the CRIC study.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
2024
Academic Article
GET IT
Times cited: 15 -
Klotho and Clinical Outcomes in CKD: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study.
American journal of kidney diseases : the official journal of the National Kidney Foundation.
2024
Academic Article
GET IT
Times cited: 12 - Associations of Kidney Functional Magnetic Resonance Imaging Biomarkers with Markers of Inflammation in Individuals with CKD. Kidney360. 2024 Article GET IT
-
Intravenous iron-induced hypophosphatemia and kidney stone disease.
Bone reports.
2024
Article
GET IT
Times cited: 6 -
Targeting Gut Microbiome With Prebiotic in Patients With CKD: The TarGut-CKD Study.
Kidney international reports.
2023
Academic Article
GET IT
Times cited: 14 - Fibroblast Growth Factor (FGF) 23 and FGF Receptor 4 promote cardiac metabolic remodeling in chronic kidney disease. Research square. 2023 Article GET IT
-
Calcium and Phosphate Disorders: Core Curriculum 2024.
American journal of kidney diseases : the official journal of the National Kidney Foundation.
2023
Information Resource
GET IT
Times cited: 37 -
Incidence, mechanism, and consequences of IV iron-induced hypophosphatemia.
Hematology. American Society of Hematology. Education Program.
2023
Academic Article
GET IT
Times cited: 14 -
Oral Sodium Bicarbonate and Bone Turnover in CKD: A Secondary Analysis of the BASE Pilot Trial.
Journal of the American Society of Nephrology : JASN.
2023
Academic Article
GET IT
Times cited: 8 -
Fibroblast Growth Factor 23 and Risk of Heart Failure Subtype: The CRIC (Chronic Renal Insufficiency Cohort) Study.
Kidney medicine.
2023
Academic Article
GET IT
Times cited: 15 -
Plasma Serotonin and Cardiovascular Outcomes in Chronic Kidney Disease.
Journal of the American Heart Association.
2023
Academic Article
GET IT
Times cited: 6 -
FGF23 and klotho at the intersection of kidney and cardiovascular disease.
Nature reviews. Cardiology.
2023
Information Resource
GET IT
Times cited: 106 -
Vitamin D Metabolites and Risk of Cardiovascular Disease in Chronic Kidney Disease: The CRIC Study.
Journal of the American Heart Association.
2023
Academic Article
GET IT
Times cited: 7 -
Matryoshka hormones.
Blood.
2023
Editorial Article
GET IT
Times cited: 1 -
Associations of FGF23 with 10-Year Change in eGFR and UACR and with Incident CKD in the CARDIA Cohort.
Kidney360.
2023
Academic Article
GET IT
Times cited: 3 - Response to Alkali Administration in Women and Men With and Without CKD. Kidney medicine. 2023 Article GET IT
-
Renal proximal tubule cells: power and finesse.
The Journal of clinical investigation.
2023
Article
GET IT
Times cited: 10 -
Sildenafil and Kidney Function in Heart Failure with Preserved Ejection Fraction.
Kidney360.
2023
Academic Article
GET IT
Times cited: 1 -
Magnesium and Fracture Risk in the General Population and Patients Receiving Dialysis: A Narrative Review.
Canadian journal of kidney health and disease.
2023
Information Resource
GET IT
Times cited: 6 - FGF23 AND ALTERED MINERAL HOMEOSTASIS IN KIDNEY DISEASE AND FOLLOWING INTRAVENOUS IRON. Transactions of the American Clinical and Climatological Association. 2023 Academic Article GET IT
-
Hepatic and renal improvements with FXR agonist vonafexor in individuals with suspected fibrotic NASH.
Journal of hepatology.
2022
Academic Article
GET IT
Times cited: 96 -
Exploring US internal medicine resident career preferences: a Q-methodology study.
Advances in health sciences education : theory and practice.
2022
Academic Article
GET IT
Times cited: 3 -
Exercising the FGF23-Cardiac Axis.
Kidney360.
2022
Editorial Article
GET IT
Times cited: 3 -
Hypophosphataemia following ferric derisomaltose and ferric carboxymaltose in patients with iron deficiency anaemia due to inflammatory bowel disease (PHOSPHARE-IBD): a randomised clinical trial.
Gut.
2022
Academic Article
GET IT
Times cited: 72 -
Supermarket Proximity and Risk of Hypertension, Diabetes, and CKD: A Retrospective Cohort Study.
American journal of kidney diseases : the official journal of the National Kidney Foundation.
2022
Academic Article
GET IT
Times cited: 18 -
The American Association of Endocrine Surgeons Guidelines for the Definitive Surgical Management of Secondary and Tertiary Renal Hyperparathyroidism.
Annals of surgery.
2022
Academic Article
GET IT
Times cited: 95 -
Risk Factors for and Effects of Persistent and Severe Hypophosphatemia Following Ferric Carboxymaltose.
The Journal of clinical endocrinology and metabolism.
2022
Academic Article
GET IT
Times cited: 43 -
A Comparative Study of Serum Phosphate and Related Parameters in Chronic Kidney Disease between the USA and Japan.
American journal of nephrology.
2022
Academic Article
GET IT
Times cited: 6 -
Risk Prediction Models for Atherosclerotic Cardiovascular Disease in Patients with Chronic Kidney Disease: The CRIC Study.
Journal of the American Society of Nephrology : JASN.
2022
Academic Article
GET IT
Times cited: 29 -
Association of circulating cardiac biomarkers with electrocardiographic abnormalities in chronic kidney disease.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
2021
Academic Article
GET IT
Times cited: 12 -
Fibroblast growth factor-23 and subclinical markers of cardiac dysfunction: The coronary artery risk development in young adults (CARDIA) study.
American heart journal.
2021
Academic Article
GET IT
Times cited: 9 -
Abnormalities in Cardiac Structure and Function among Individuals with CKD: The COMBINE Trial.
Kidney360.
2021
Academic Article
GET IT
Times cited: 3 -
Race, Genetic Ancestry, and Estimating Kidney Function in CKD.
The New England journal of medicine.
2021
Academic Article
GET IT
Times cited: 192 -
Hypophosphatemia after intravenous iron therapy: Comprehensive review of clinical findings and recommendations for management.
Bone.
2021
Information Resource
GET IT
Times cited: 105 -
Noninvasive Risk Score to Screen for Pulmonary Hypertension With Elevated Pulmonary Vascular Resistance in Diseases of Chronic Volume Overload.
The American journal of cardiology.
2021
Academic Article
GET IT
Times cited: 1 -
Fibroblast Growth Factor 23 and Incident Cardiovascular Disease and Mortality in Middle-Aged Adults.
Journal of the American Heart Association.
2021
Academic Article
GET IT
Times cited: 13 -
Lipocalin 2 stimulates bone fibroblast growth factor 23 production in chronic kidney disease.
Bone research.
2021
Academic Article
GET IT
Times cited: 45 -
Iron status, fibroblast growth factor 23 and cardiovascular and kidney outcomes in chronic kidney disease.
Kidney international.
2021
Academic Article
GET IT
Times cited: 27 -
Intravenous Iron-Induced Hypophosphatemia: An Emerging Syndrome.
Advances in therapy.
2021
Information Resource
GET IT
Times cited: 39 -
Time-Updated Changes in Estimated GFR and Proteinuria and Major Adverse Cardiac Events: Findings from the Chronic Renal Insufficiency Cohort (CRIC) Study.
American journal of kidney diseases : the official journal of the National Kidney Foundation.
2021
Academic Article
GET IT
Times cited: 19 -
Pivoting From PTH to FGF23 to Mend Breaking Hearts on Dialysis.
Circulation research.
2021
Editorial Article
GET IT
Times cited: 4 -
International Society of Nephrology Global Kidney Health Atlas: structures, organization, and services for the management of kidney failure in North America and the Caribbean.
Kidney international supplements.
2021
Information Resource
GET IT
Times cited: 15 -
Safety and efficacy of iron isomaltoside 1000/ferric derisomaltose versus iron sucrose in patients with chronic kidney disease: the FERWON-NEPHRO randomized, open-label, comparative trial.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
2021
Academic Article
GET IT
Times cited: 79 -
Change in Cardiac Biomarkers and Risk of Incident Heart Failure and Atrial Fibrillation in CKD: The Chronic Renal Insufficiency Cohort (CRIC) Study.
American journal of kidney diseases : the official journal of the National Kidney Foundation.
2020
Academic Article
GET IT
Times cited: 29 -
Hypophosphataemia after treatment of iron deficiency with intravenous ferric carboxymaltose or iron isomaltoside-a systematic review and meta-analysis.
British journal of clinical pharmacology.
2020
Information Resource
GET IT
Times cited: 112 -
Design and Rationale of HiLo: A Pragmatic, Randomized Trial of Phosphate Management for Patients Receiving Maintenance Hemodialysis.
American journal of kidney diseases : the official journal of the National Kidney Foundation.
2020
Academic Article
GET IT
Times cited: 42 -
Safety of ferric derisomaltose and iron sucrose in patients with iron deficiency anemia: The FERWON-IDA/NEPHRO trials.
American journal of hematology.
2020
Article
GET IT
Times cited: 20 -
Fibroblast Growth Factor 23 and Exercise Capacity in Heart Failure with Preserved Ejection Fraction.
Journal of cardiac failure.
2020
Academic Article
GET IT
Times cited: 14 -
Echocardiography to Screen for Pulmonary Hypertension in CKD.
Kidney international reports.
2020
Academic Article
GET IT
Times cited: 4 -
Mineral bone disease in autosomal dominant polycystic kidney disease.
Kidney international.
2020
Academic Article
GET IT
Times cited: 23 -
Novel Risk Factors for Progression of Diabetic and Nondiabetic CKD: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study.
American journal of kidney diseases : the official journal of the National Kidney Foundation.
2020
Academic Article
GET IT
Times cited: 73 -
Association between patient race and staff resuscitation efforts after cardiac arrest in outpatient dialysis clinics: A study from the CARES surveillance group.
Resuscitation.
2020
Academic Article
GET IT
Times cited: 9 -
Mechanism of action of SNF472, a novel calcification inhibitor to treat vascular calcification and calciphylaxis.
British journal of pharmacology.
2020
Academic Article
GET IT
Times cited: 40 -
The Nephrology Immersion Classroom for Internal Medicine Residents.
Kidney360.
2020
Academic Article
GET IT
Times cited: 4 -
Drug Development in Kidney Disease: Proceedings From a Multistakeholder Conference.
American journal of kidney diseases : the official journal of the National Kidney Foundation.
2020
Information Resource
GET IT
Times cited: 4 -
Anemia and Incident End-Stage Kidney Disease.
Kidney360.
2020
Academic Article
GET IT
Times cited: 13 -
Interactions between FGF23 and Genotype in Autosomal Dominant Polycystic Kidney Disease.
Kidney360.
2020
Academic Article
GET IT
Times cited: 5 -
Effects of ferric carboxymaltose on markers of mineral and bone metabolism: A single-center prospective observational study of women with iron deficiency.
Bone.
2020
Academic Article
GET IT
Times cited: 17 -
Nephropathic Cystinosis: A Distinct Form of CKD-Mineral and Bone Disorder that Provides Novel Insights into the Regulation of FGF23.
Journal of the American Society of Nephrology : JASN.
2020
Academic Article
GET IT
Times cited: 17 -
Fibroblast Growth Factor 23 and Risk of Hospitalization with Infection in Chronic Kidney Disease: The Chronic Renal Insufficiency Cohort (CRIC) Study.
Journal of the American Society of Nephrology : JASN.
2020
Academic Article
GET IT
Times cited: 22 -
Designing, Conducting, Monitoring, and Analyzing Data from Pragmatic Randomized Clinical Trials: Proceedings from a Multi-stakeholder Think Tank Meeting.
Therapeutic innovation & regulatory science.
2020
Academic Article
GET IT
Times cited: 13 -
Inflammatory Markers and Incidence of Hospitalization With Infection in Chronic Kidney Disease.
American journal of epidemiology.
2020
Academic Article
GET IT
Times cited: 20 - Health Outcomes With Vitamin D Supplementation-Reply. JAMA. 2020 Article GET IT
-
Kidney Functional Magnetic Resonance Imaging and Change in eGFR in Individuals with CKD.
Clinical journal of the American Society of Nephrology : CJASN.
2020
Academic Article
GET IT
Times cited: 40 -
Targeting Vascular Calcification in Chronic Kidney Disease.
JACC. Basic to translational science.
2020
Information Resource
GET IT
Times cited: 142 -
Fibroblast Growth Factor-23 and a Vegetarian Diet.
Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation.
2020
Academic Article
GET IT
Times cited: 3 -
Racial Differences in the Associations Between Food Insecurity and Fibroblast Growth Factor 23 in the Coronary Artery Risk Development in Young Adults Study.
Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation.
2020
Academic Article
GET IT
Times cited: 7 -
Kidney to bone via bedside to bench…and back?.
The Journal of clinical investigation.
2020
Article
GET IT
Times cited: 1 -
Effects of Iron Isomaltoside vs Ferric Carboxymaltose on Hypophosphatemia in Iron-Deficiency Anemia: Two Randomized Clinical Trials.
JAMA.
2020
Academic Article
GET IT
Times cited: 241 -
Creatinine versus cystatin C for renal function-based mortality prediction in an elderly cohort: The Northern Manhattan Study.
PloS one.
2020
Academic Article
GET IT
Times cited: 31 -
Serial Fibroblast Growth Factor 23 Measurements and Risk of Requirement for Kidney Replacement Therapy: The CRIC (Chronic Renal Insufficiency Cohort) Study.
American journal of kidney diseases : the official journal of the National Kidney Foundation.
2019
Academic Article
GET IT
Times cited: 16 -
A Randomized Trial Comparing the Safety, Adherence, and Pharmacodynamics Profiles of Two Doses of Sodium Bicarbonate in CKD: the BASE Pilot Trial.
Journal of the American Society of Nephrology : JASN.
2019
Academic Article
GET IT
Times cited: 49 -
Regulation and Effects of FGF23 in Chronic Kidney Disease.
Annual review of physiology.
2019
Information Resource
GET IT
Times cited: 105 -
Vitamin D and Health Outcomes: Then Came the Randomized Clinical Trials.
JAMA.
2019
Academic Article
GET IT
Times cited: 30 -
Pulmonary Hypertension Subtypes and Mortality in CKD.
American journal of kidney diseases : the official journal of the National Kidney Foundation.
2019
Academic Article
GET IT
Times cited: 54 -
Longitudinal Evolution of Markers of Mineral Metabolism in Patients With CKD: The Chronic Renal Insufficiency Cohort (CRIC) Study.
American journal of kidney diseases : the official journal of the National Kidney Foundation.
2019
Academic Article
GET IT
Times cited: 64 -
FGFR4 does not contribute to progression of chronic kidney disease.
Scientific reports.
2019
Academic Article
GET IT
Times cited: 16 -
FGF23 at the crossroads of phosphate, iron economy and erythropoiesis.
Nature reviews. Nephrology.
2019
Information Resource
GET IT
Times cited: 211 -
Does a rise in plasma erythropoietin after high-altitude exposure affect FGF23 in healthy volunteers on a normal or low-phosphorus diet?.
Nutrition, metabolism, and cardiovascular diseases : NMCD.
2019
Academic Article
GET IT
Times cited: 5 -
Editorial: awareness and prevention of intravenous iron-induced hypophosphataemia.
Alimentary pharmacology & therapeutics.
2019
Editorial Article
GET IT
Times cited: 1 -
Ferric citrate reduces fibroblast growth factor 23 levels and improves renal and cardiac function in a mouse model of chronic kidney disease.
Kidney international.
2019
Academic Article
GET IT
Times cited: 54 -
Vitamin D Metabolic Ratio and Risks of Death and CKD Progression.
Kidney international reports.
2019
Academic Article
GET IT
Times cited: 23 -
Single Measurements of Carboxy-Terminal Fibroblast Growth Factor 23 and Clinical Risk Prediction of Adverse Outcomes in CKD.
American journal of kidney diseases : the official journal of the National Kidney Foundation.
2019
Academic Article
GET IT
Times cited: 16 -
Cardiac Biomarkers and Risk of Atrial Fibrillation in Chronic Kidney Disease: The CRIC Study.
Journal of the American Heart Association.
2019
Academic Article
GET IT
Times cited: 28 -
A Pilot Randomized Trial of Ferric Citrate Coordination Complex for the Treatment of Advanced CKD.
Journal of the American Society of Nephrology : JASN.
2019
Academic Article
GET IT
Times cited: 63 -
Association of Fitness With Racial Differences in Chronic Kidney Disease.
American journal of preventive medicine.
2019
Academic Article
GET IT
Times cited: 10 -
GFR-Specific versus GFR-Agnostic Cutoffs for Parathyroid Hormone and Fibroblast Growth Factor-23 in Advanced Chronic Kidney Disease.
American journal of nephrology.
2019
Academic Article
GET IT
Times cited: 8 -
Randomised clinical trial of ferric citrate hydrate on anaemia management in haemodialysis patients with hyperphosphataemia: ASTRIO study.
Scientific reports.
2019
Academic Article
GET IT
Times cited: 29 -
Modifiers of Plasma 25-Hydroxyvitamin D and Chronic Kidney Disease Outcomes in Black Americans: The Jackson Heart Study.
The Journal of clinical endocrinology and metabolism.
2019
Academic Article
GET IT
Times cited: 6 -
Effects of Nicotinamide and Lanthanum Carbonate on Serum Phosphate and Fibroblast Growth Factor-23 in CKD: The COMBINE Trial.
Journal of the American Society of Nephrology : JASN.
2019
Academic Article
GET IT
Times cited: 97 -
Effects of etelcalcetide on fibroblast growth factor 23 in patients with secondary hyperparathyroidism receiving hemodialysis.
Clinical kidney journal.
2019
Academic Article
GET IT
Times cited: 23 -
DMP1 prevents osteocyte alterations, FGF23 elevation and left ventricular hypertrophy in mice with chronic kidney disease.
Bone research.
2019
Academic Article
GET IT
Times cited: 84 -
Serum Calcification Propensity and Coronary Artery Calcification Among Patients With CKD: The CRIC (Chronic Renal Insufficiency Cohort) Study.
American journal of kidney diseases : the official journal of the National Kidney Foundation.
2019
Academic Article
GET IT
Times cited: 79 -
Predictors of Net Acid Excretion in the Chronic Renal Insufficiency Cohort (CRIC) Study.
American journal of kidney diseases : the official journal of the National Kidney Foundation.
2019
Academic Article
GET IT
Times cited: 7 -
Fibroblast Growth Factor 23 Trajectories in Chronic Hemodialysis Patients: Lessons from the HEMO Study.
American journal of nephrology.
2019
Academic Article
GET IT
Times cited: 12 -
The effects of tenapanor on serum fibroblast growth factor 23 in patients receiving hemodialysis with hyperphosphatemia.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
2019
Academic Article
GET IT
Times cited: 35 -
Fibroblast Growth Factor-23, Heart Failure Risk, and Renin-Angiotensin-Aldosterone-System Blockade in Hypertension: The MESA Study.
American journal of hypertension.
2019
Academic Article
GET IT
Times cited: 18 -
Good Guys, Bad Guys, Guesses, and Near Misses in Nephrology.
Clinical journal of the American Society of Nephrology : CJASN.
2018
Editorial Article
GET IT
Times cited: 1 -
Use of Measures of Inflammation and Kidney Function for Prediction of Atherosclerotic Vascular Disease Events and Death in Patients With CKD: Findings From the CRIC Study.
American journal of kidney diseases : the official journal of the National Kidney Foundation.
2018
Academic Article
GET IT
Times cited: 133 -
Randomized trial of intravenous iron-induced hypophosphatemia.
JCI insight.
2018
Academic Article
GET IT
Times cited: 168 -
Creatinine- versus cystatin C-based renal function assessment in the Northern Manhattan Study.
PloS one.
2018
Academic Article
GET IT
Times cited: 18 -
Chicago supermarket data and food access analytics in census tract shapefiles for 2007-2014.
Data in brief.
2018
Academic Article
GET IT
Times cited: 11 -
Statins at Dialysis Transition-Supportive but Not Sufficient.
JAMA network open.
2018
Article
GET IT
Times cited: 2 -
Health Behaviors in Younger and Older Adults With CKD: Results From the CRIC Study.
Kidney international reports.
2018
Academic Article
GET IT
Times cited: 20 -
Genetic Variants Associated with Circulating Fibroblast Growth Factor 23.
Journal of the American Society of Nephrology : JASN.
2018
Information Resource
GET IT
Times cited: 34 -
Fibroblast growth factor23 is associated with axonal integrity and neural network architecture in the human frontal lobes.
PloS one.
2018
Academic Article
GET IT
Times cited: 18 -
Urban foodscape trends: Disparities in healthy food access in Chicago, 2007-2014.
Health & place.
2018
Academic Article
GET IT
Times cited: 69 -
Multicenter Study Evaluating Intrarenal Oxygenation and Fibrosis Using Magnetic Resonance Imaging in Individuals With Advanced CKD.
Kidney international reports.
2018
Academic Article
GET IT
Times cited: 14 -
Sleep disordered breathing and fibroblast growth factor 23 in the Hispanic Community Health Study/Study of Latinos.
Bone.
2018
Academic Article
GET IT
Times cited: 5 -
Genetic background influences cardiac phenotype in murine chronic kidney disease.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
2018
Academic Article
GET IT
Times cited: 28 -
Metabolic Changes with Base-Loading in CKD.
Clinical journal of the American Society of Nephrology : CJASN.
2018
Article
GET IT
Times cited: 7 -
Incidence and Progression of Chronic Kidney Disease in Black and White Individuals with Type 2 Diabetes.
Clinical journal of the American Society of Nephrology : CJASN.
2018
Academic Article
GET IT
Times cited: 28 -
FGF23 (Fibroblast Growth Factor-23) and Incident Hypertension in Young and Middle-Aged Adults: The CARDIA Study.
Hypertension (Dallas, Tex. : 1979).
2018
Academic Article
GET IT
Times cited: 38 -
Fibroblast Growth Factor 23 Associates with Death in Critically Ill Patients.
Clinical journal of the American Society of Nephrology : CJASN.
2018
Academic Article
GET IT
Times cited: 50 -
Biomarkers of Mineral and Bone Metabolism and 20-Year Risk of Hospitalization With Infection: The Atherosclerosis Risk in Communities Study.
The Journal of clinical endocrinology and metabolism.
2017
Academic Article
GET IT
Times cited: 12 -
Longitudinal FGF23 Trajectories and Mortality in Patients with CKD.
Journal of the American Society of Nephrology : JASN.
2017
Academic Article
GET IT
Times cited: 116 -
Oral Ferric Citrate Hydrate Associated With Less Oxidative Stress Than Intravenous Saccharated Ferric Oxide.
Kidney international reports.
2017
Academic Article
GET IT
Times cited: 6 -
FGF23 and Left Ventricular Hypertrophy in Children with CKD.
Clinical journal of the American Society of Nephrology : CJASN.
2017
Academic Article
GET IT
Times cited: 89 -
Prognostic value of bone- and vascular-derived molecular biomarkers in hemodialysis and renal transplant patients: a systematic review and meta-analysis.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
2017
Information Resource
GET IT
Times cited: 23 -
Fibroblast Growth Factor 23 and Anemia in the Chronic Renal Insufficiency Cohort Study.
Clinical journal of the American Society of Nephrology : CJASN.
2017
Academic Article
GET IT
Times cited: 65 -
Effects of Vitamin D2 Supplementation on Vitamin D3 Metabolism in Health and CKD.
Clinical journal of the American Society of Nephrology : CJASN.
2017
Academic Article
GET IT
Times cited: 43 -
Racial/Ethnic Differences in Left Ventricular Structure and Function in Chronic Kidney Disease: The Chronic Renal Insufficiency Cohort.
American journal of hypertension.
2017
Academic Article
GET IT
Times cited: 16 -
FGF23 and Nutritional Metabolism.
Annual review of nutrition.
2017
Information Resource
GET IT
Times cited: 25 -
Fibroblast Growth Factor 23 and Kidney Disease Progression in Autosomal Dominant Polycystic Kidney Disease.
Clinical journal of the American Society of Nephrology : CJASN.
2017
Academic Article
GET IT
Times cited: 25 -
Something old, something new, something borrowed, something black.
Current opinion in nephrology and hypertension.
2017
Editorial Article
GET IT
Times cited: 2 -
Acid Load and Phosphorus Homeostasis in CKD.
American journal of kidney diseases : the official journal of the National Kidney Foundation.
2017
Academic Article
GET IT
Times cited: 37 - Coronary Artery Calcification and Risk of Cardiovascular Disease and Death Among Patients With Chronic Kidney Disease. JAMA cardiology. 2017 Academic Article GET IT
- The Authors Reply. Kidney international. 2017 Article GET IT
-
Risk Factors for Heart Failure in Patients With Chronic Kidney Disease: The CRIC (Chronic Renal Insufficiency Cohort) Study.
Journal of the American Heart Association.
2017
Academic Article
GET IT
Times cited: 86 -
FGF23/FGFR4-mediated left ventricular hypertrophy is reversible.
Scientific reports.
2017
Academic Article
GET IT
Times cited: 110 -
Klotho, an antiaging molecule, attenuates oxidant-induced alveolar epithelial cell mtDNA damage and apoptosis.
American journal of physiology. Lung cellular and molecular physiology.
2017
Academic Article
GET IT
Times cited: 45 -
Statistical Methods for Cohort Studies of CKD: Survival Analysis in the Setting of Competing Risks.
Clinical journal of the American Society of Nephrology : CJASN.
2017
Academic Article
GET IT
Times cited: 63 -
Second Chances to Improve ESRD Outcomes With a Second-Generation Calcimimetic.
JAMA.
2017
Editorial Article
GET IT
Times cited: 5 -
Serum levels of fibroblast growth factor 23 are elevated in patients with active Lupus nephritis.
Cytokine.
2017
Academic Article
GET IT
Times cited: 12 -
Fibroblast Growth Factor 23 Levels Associate with AKI and Death in Critical Illness.
Journal of the American Society of Nephrology : JASN.
2016
Academic Article
GET IT
Times cited: 87 -
Inflammation and elevated levels of fibroblast growth factor 23 are independent risk factors for death in chronic kidney disease.
Kidney international.
2016
Academic Article
GET IT
Times cited: 117 -
Dietary factors and fibroblast growth factor-23 levels in young adults with African ancestry.
Journal of bone and mineral metabolism.
2016
Academic Article
GET IT
Times cited: 10 -
Genetic Variants Associated with Circulating Parathyroid Hormone.
Journal of the American Society of Nephrology : JASN.
2016
Academic Article
GET IT
Times cited: 59 -
Higher net acid excretion is associated with a lower risk of kidney disease progression in patients with diabetes.
Kidney international.
2016
Academic Article
GET IT
Times cited: 53 -
Asymptomatic Ventricular Arrhythmia and Clinical Outcomes in Chronic Kidney Disease: A Pilot Study.
Cardiorenal medicine.
2016
Academic Article
GET IT
Times cited: 9 -
Fibroblast Growth Factor 23 and Risk of CKD Progression in Children.
Clinical journal of the American Society of Nephrology : CJASN.
2016
Academic Article
GET IT
Times cited: 68 -
Fibroblast Growth Factor 23 and Cause-Specific Mortality in the General Population: The Northern Manhattan Study.
The Journal of clinical endocrinology and metabolism.
2016
Academic Article
GET IT
Times cited: 77 -
Association of Fibroblast Growth Factor 23 With Atrial Fibrillation in Chronic Kidney Disease, From the Chronic Renal Insufficiency Cohort Study.
JAMA cardiology.
2016
Academic Article
GET IT
Times cited: 95 -
Fibroblast growth factor 23 directly targets hepatocytes to promote inflammation in chronic kidney disease.
Kidney international.
2016
Academic Article
GET IT
Times cited: 318 - Mineral metabolism: progress in the face of complexity. Current opinion in nephrology and hypertension. 2016 Editorial Article GET IT
-
Race/Ethnicity and Cardiovascular Outcomes in Adults With CKD: Findings From the CRIC (Chronic Renal Insufficiency Cohort) and Hispanic CRIC Studies.
American journal of kidney diseases : the official journal of the National Kidney Foundation.
2016
Academic Article
GET IT
Times cited: 34 -
Atrial Fibrillation and Risk of ESRD in Adults with CKD.
Clinical journal of the American Society of Nephrology : CJASN.
2016
Academic Article
GET IT
Times cited: 84 -
Fibroblast Growth Factor-23 (FGF-23) Levels Differ Across Populations by Degree of Industrialization.
The Journal of clinical endocrinology and metabolism.
2016
Academic Article
GET IT
Times cited: 21 -
Fibroblast Growth Factor 23 Is Associated With Subclinical Cerebrovascular Damage: The Northern Manhattan Study.
Stroke.
2016
Academic Article
GET IT
Times cited: 27 -
Fibroblast growth factor 23 levels are elevated and associated with severe acute kidney injury and death following cardiac surgery.
Kidney international.
2016
Academic Article
GET IT
Times cited: 82 -
Cord Blood Ferritin and Fibroblast Growth Factor-23 Levels in Neonates.
The Journal of clinical endocrinology and metabolism.
2016
Academic Article
GET IT
Times cited: 17 -
Genetic African Ancestry and Markers of Mineral Metabolism in CKD.
Clinical journal of the American Society of Nephrology : CJASN.
2016
Academic Article
GET IT
Times cited: 16 -
Pruning the ricket thicket.
The Journal of clinical investigation.
2016
Article
GET IT
Times cited: 2 -
Inflammation and functional iron deficiency regulate fibroblast growth factor 23 production.
Kidney international.
2016
Academic Article
GET IT
Times cited: 434 -
A Prospective Cohort Study of Mineral Metabolism After Kidney Transplantation.
Transplantation.
2016
Academic Article
GET IT
Times cited: 135 -
Food Access, Chronic Kidney Disease, and Hypertension in the U.S.
American journal of preventive medicine.
2015
Academic Article
GET IT
Times cited: 116 -
Activation of Cardiac Fibroblast Growth Factor Receptor 4 Causes Left Ventricular Hypertrophy.
Cell metabolism.
2015
Academic Article
GET IT
Times cited: 486 -
Examination of Potential Modifiers of the Association of APOL1 Alleles with CKD Progression.
Clinical journal of the American Society of Nephrology : CJASN.
2015
Academic Article
GET IT
Times cited: 33 - Fibroblast Growth Factor-23 Fans the Flames of Heart and Kidney Failure. JACC. Heart failure. 2015 Editorial Article GET IT
-
Hunt for the culprit of cardiovascular injury in kidney disease.
Cardiovascular research.
2015
Editorial Article
GET IT
Times cited: 11 -
Mineral (Mal)Adaptation to Kidney Disease--Young Investigator Award Address: American Society of Nephrology Kidney Week 2014.
Clinical journal of the American Society of Nephrology : CJASN.
2015
Conference Paper
GET IT
Times cited: 31 -
When there will never be a randomized controlled trial.
Kidney international.
2015
Article
GET IT
Times cited: 11 -
The Association Between Conversion to In-centre Nocturnal Hemodialysis and Left Ventricular Mass Regression in Patients With End-Stage Renal Disease.
The Canadian journal of cardiology.
2015
Academic Article
GET IT
Times cited: 32 - Bones and stones, edition 2015. Current opinion in nephrology and hypertension. 2015 Editorial Article GET IT
-
Fibroblast Growth Factor 23 Is Associated With Carotid Plaque Presence and Area: The Northern Manhattan Study.
Arteriosclerosis, thrombosis, and vascular biology.
2015
Academic Article
GET IT
Times cited: 31 -
Rationale and Approaches to Phosphate and Fibroblast Growth Factor 23 Reduction in CKD.
Journal of the American Society of Nephrology : JASN.
2015
Information Resource
GET IT
Times cited: 124 -
Phosphate, fibroblast growth factor 23 and retinopathy in chronic kidney disease: the Chronic Renal Insufficiency Cohort Study.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
2015
Academic Article
GET IT
Times cited: 12 -
Persistent high serum bicarbonate and the risk of heart failure in patients with chronic kidney disease (CKD): A report from the Chronic Renal Insufficiency Cohort (CRIC) study.
Journal of the American Heart Association.
2015
Academic Article
GET IT
Times cited: 85 -
Serum Phosphorus and Progression of CKD and Mortality: A Meta-analysis of Cohort Studies.
American journal of kidney diseases : the official journal of the National Kidney Foundation.
2015
Information Resource
GET IT
Times cited: 137 -
A 12-week, double-blind, placebo-controlled trial of ferric citrate for the treatment of iron deficiency anemia and reduction of serum phosphate in patients with CKD Stages 3-5.
American journal of kidney diseases : the official journal of the National Kidney Foundation.
2014
Academic Article
GET IT
Times cited: 126 -
Impact of westernization on fibroblast growth factor 23 levels among individuals of African ancestry.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
2014
Academic Article
GET IT
Times cited: 20 -
Vitamin D therapy in individuals with prehypertension or hypertension: the DAYLIGHT trial.
Circulation.
2014
Academic Article
GET IT
Times cited: 109 -
Fibroblast growth factor 23 and incident CKD in type 2 diabetes.
Clinical journal of the American Society of Nephrology : CJASN.
2014
Academic Article
GET IT
Times cited: 26 -
Klotho and phosphate are modulators of pathologic uremic cardiac remodeling.
Journal of the American Society of Nephrology : JASN.
2014
Academic Article
GET IT
Times cited: 254 -
High-sensitivity troponin T and N-terminal pro-B-type natriuretic peptide (NT-proBNP) and risk of incident heart failure in patients with CKD: the Chronic Renal Insufficiency Cohort (CRIC) Study.
Journal of the American Society of Nephrology : JASN.
2014
Academic Article
GET IT
Times cited: 119 -
The biomarker niche for fibroblast growth factor 23 testing in CKD.
Journal of the American Society of Nephrology : JASN.
2014
Editorial Article
GET IT
Times cited: 6 -
Coupling fibroblast growth factor 23 production and cleavage: iron deficiency, rickets, and kidney disease.
Current opinion in nephrology and hypertension.
2014
Information Resource
GET IT
Times cited: 173 -
The pursuit of truth and beauty.
Current opinion in nephrology and hypertension.
2014
Editorial Article
GET IT
Times cited: 1 -
Treatment of established left ventricular hypertrophy with fibroblast growth factor receptor blockade in an animal model of CKD.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
2014
Academic Article
GET IT
Times cited: 84 -
In search of the fountain of youth.
Journal of the American Society of Nephrology : JASN.
2014
Editorial Article
GET IT
Times cited: 3 -
Nephrogenic systemic fibrosis is associated with hypophosphataemia: a case-control study.
Rheumatology (Oxford, England).
2014
Academic Article
GET IT
Times cited: 8 -
Plasma FGF23 and the risk of stroke: the Northern Manhattan Study (NOMAS).
Neurology.
2014
Academic Article
GET IT
Times cited: 62 -
Roles of phosphate and fibroblast growth factor 23 in cardiovascular disease.
Nature reviews. Nephrology.
2014
Information Resource
GET IT
Times cited: 174 -
Increasing use of vitamin D supplementation in the chronic renal insufficiency cohort study.
Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation.
2014
Academic Article
GET IT
Times cited: 10 -
Disordered FGF23 and mineral metabolism in children with CKD.
Clinical journal of the American Society of Nephrology : CJASN.
2013
Academic Article
GET IT
Times cited: 134 -
Correlates of left ventricular mass in chronic hemodialysis recipients.
The international journal of cardiovascular imaging.
2013
Academic Article
GET IT
Times cited: 18 -
Fibroblast growth factor-23 and cardiovascular events in CKD.
Journal of the American Society of Nephrology : JASN.
2013
Academic Article
GET IT
Times cited: 395 -
Predictors of high sensitivity cardiac troponin T in chronic kidney disease patients: a cross-sectional study in the chronic renal insufficiency cohort (CRIC).
BMC nephrology.
2013
Academic Article
GET IT
Times cited: 145 -
Effects of iron deficiency anemia and its treatment on fibroblast growth factor 23 and phosphate homeostasis in women.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
2013
Academic Article
GET IT
Times cited: 349 - Innovations in bones and stones. Current opinion in nephrology and hypertension. 2013 Editorial Article GET IT
-
Phosphate homeostasis in CKD: report of a scientific symposium sponsored by the National Kidney Foundation.
American journal of kidney diseases : the official journal of the National Kidney Foundation.
2013
Information Resource
GET IT
Times cited: 73 -
FGF23 modifies the relationship between vitamin D and cardiac remodeling.
Circulation. Heart failure.
2013
Academic Article
GET IT
Times cited: 50 -
Plasma FGF23 levels increase rapidly after acute kidney injury.
Kidney international.
2013
Academic Article
GET IT
Times cited: 161 -
A balanced view of calcium and phosphate homeostasis in chronic kidney disease.
Kidney international.
2013
Article
GET IT
Times cited: 28 -
Dysregulated mineral metabolism in patients with acute kidney injury and risk of adverse outcomes.
Clinical endocrinology.
2013
Academic Article
GET IT
Times cited: 61 -
Association of serum bicarbonate with risk of renal and cardiovascular outcomes in CKD: a report from the Chronic Renal Insufficiency Cohort (CRIC) study.
American journal of kidney diseases : the official journal of the National Kidney Foundation.
2013
Academic Article
GET IT
Times cited: 218 -
Effects of dietary phosphate restriction and phosphate binders on FGF23 levels in CKD.
Clinical journal of the American Society of Nephrology : CJASN.
2013
Academic Article
GET IT
Times cited: 130 - Contemporary mineral metabolism for clinicians and scientists: introduction. Seminars in nephrology. 2013 Editorial Article GET IT
-
Fibroblast growth factor 23 is not associated with and does not induce arterial calcification.
Kidney international.
2013
Academic Article
GET IT
Times cited: 289 -
Mineral metabolites and CKD progression in African Americans.
Journal of the American Society of Nephrology : JASN.
2012
Academic Article
GET IT
Times cited: 93 -
αKlotho: FGF23 coreceptor and FGF23-regulating hormone.
The Journal of clinical investigation.
2012
Article
GET IT
Times cited: 17 -
Genetic variants and associations of 25-hydroxyvitamin D concentrations with major clinical outcomes.
JAMA.
2012
Academic Article
GET IT
Times cited: 173 -
Phosphate: a novel cardiovascular risk factor.
European heart journal.
2012
Academic Article
GET IT
Times cited: 28 -
Partial answers from partial Klotho deficiency.
Journal of the American Society of Nephrology : JASN.
2012
Editorial Article
GET IT
Times cited: 2 -
A physiologic-based approach to the evaluation of a patient with hyperphosphatemia.
American journal of kidney diseases : the official journal of the National Kidney Foundation.
2012
Article
GET IT
Times cited: 16 -
Expression of fgf23 and αklotho in developing embryonic tissues and adult kidney of the zebrafish, Danio rerio.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
2012
Academic Article
GET IT
Times cited: 35 -
Fibroblast growth factor 23, high-sensitivity cardiac troponin, and left ventricular hypertrophy in CKD.
American journal of kidney diseases : the official journal of the National Kidney Foundation.
2012
Academic Article
GET IT
Times cited: 37 -
Effects of phosphate binders in moderate CKD.
Journal of the American Society of Nephrology : JASN.
2012
Academic Article
GET IT
Times cited: 477 -
Interpreting cardiac troponin results from high-sensitivity assays in chronic kidney disease without acute coronary syndrome.
Clinical chemistry.
2012
Academic Article
GET IT
Times cited: 150 - Mineral metabolism: confusion to clarity. Current opinion in nephrology and hypertension. 2012 Editorial Article GET IT
-
FGF-23 levels in patients with AKI and risk of adverse outcomes.
Clinical journal of the American Society of Nephrology : CJASN.
2012
Academic Article
GET IT
Times cited: 86 -
Update on fibroblast growth factor 23 in chronic kidney disease.
Kidney international.
2012
Information Resource
GET IT
Times cited: 342 -
Fibroblast growth factor 23 and Inflammation in CKD.
Clinical journal of the American Society of Nephrology : CJASN.
2012
Academic Article
GET IT
Times cited: 239 -
Plant protein intake is associated with fibroblast growth factor 23 and serum bicarbonate levels in patients with chronic kidney disease: the Chronic Renal Insufficiency Cohort study.
Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation.
2012
Academic Article
GET IT
Times cited: 98 -
Earlier onset and greater severity of disordered mineral metabolism in diabetic patients with chronic kidney disease.
Diabetes care.
2012
Academic Article
GET IT
Times cited: 71 -
Associations of dietary phosphorus intake, urinary phosphate excretion, and fibroblast growth factor 23 with vascular stiffness in chronic kidney disease.
Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation.
2012
Academic Article
GET IT
Times cited: 26 -
Tubular markers are associated with decline in kidney function in proteinuric type 2 diabetic patients.
Diabetes research and clinical practice.
2012
Academic Article
GET IT
Times cited: 84 -
Paricalcitol versus cinacalcet plus low-dose vitamin D therapy for the treatment of secondary hyperparathyroidism in patients receiving haemodialysis: results of the IMPACT SHPT study.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
2012
Academic Article
GET IT
Times cited: 102 -
Daily variability in mineral metabolites in CKD and effects of dietary calcium and calcitriol.
Clinical journal of the American Society of Nephrology : CJASN.
2012
Academic Article
GET IT
Times cited: 50 -
Associations of socioeconomic status and processed food intake with serum phosphorus concentration in community-living adults: the Multi-Ethnic Study of Atherosclerosis (MESA).
Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation.
2012
Academic Article
GET IT
Times cited: 24 -
(1-34) Parathyroid hormone infusion acutely lowers fibroblast growth factor 23 concentrations in adult volunteers.
Clinical journal of the American Society of Nephrology : CJASN.
2012
Academic Article
GET IT
Times cited: 32 -
FGF23 in chronic kidney disease.
Advances in experimental medicine and biology.
2012
Information Resource
GET IT
Times cited: 70 -
The confounding effect of systemic physiology on the hemodynamic response in newborns.
Advances in experimental medicine and biology.
2012
Academic Article
GET IT
Times cited: 15 -
Association of serum calcitonin with coronary artery disease in individuals with and without chronic kidney disease.
International urology and nephrology.
2011
Academic Article
GET IT
Times cited: 8 -
Fibroblast growth factor 23, cardiovascular disease risk factors, and phosphorus intake in the health professionals follow-up study.
Clinical journal of the American Society of Nephrology : CJASN.
2011
Academic Article
GET IT
Times cited: 142 -
FGF23 induces left ventricular hypertrophy.
The Journal of clinical investigation.
2011
Academic Article
GET IT
Times cited: 1814 -
Correlates of osteoprotegerin and association with aortic pulse wave velocity in patients with chronic kidney disease.
Clinical journal of the American Society of Nephrology : CJASN.
2011
Academic Article
GET IT
Times cited: 51 -
Fibroblast growth factor 23 in patients undergoing peritoneal dialysis.
Clinical journal of the American Society of Nephrology : CJASN.
2011
Academic Article
GET IT
Times cited: 80 -
Phosphate REINs in the renoprotective benefit of ACE inhibition.
Journal of the American Society of Nephrology : JASN.
2011
Editorial Article
GET IT
Times cited: 1 - The beehive and the merry-go-round in mineral metabolism. Current opinion in nephrology and hypertension. 2011 Editorial Article GET IT
-
Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease.
JAMA.
2011
Academic Article
GET IT
Times cited: 922 -
Differential effects of vitamin d receptor agonists on gene expression in neonatal rat cardiomyocytes.
Cardiovascular drugs and therapy.
2011
Academic Article
GET IT
Times cited: 6 -
Association of serum phosphorus level with anemia in kidney transplant recipients.
Transplantation.
2011
Academic Article
GET IT
Times cited: 28 -
Elevated fibroblast growth factor 23 is a risk factor for kidney transplant loss and mortality.
Journal of the American Society of Nephrology : JASN.
2011
Academic Article
GET IT
Times cited: 251 -
Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease.
Kidney international.
2011
Academic Article
GET IT
Times cited: 1111 -
Diuretics, calciuria and secondary hyperparathyroidism in the Chronic Renal Insufficiency Cohort.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
2011
Academic Article
GET IT
Times cited: 42 -
Should activated vitamin D be used in patients with end-stage renal disease and low levels of parathyroid hormone?.
Seminars in dialysis.
2011
Academic Article
GET IT
Times cited: 3 -
FGF23 or PTH: which comes first in CKD ?.
Kidney international.
2010
Article
GET IT
Times cited: 68 -
Tertiary excess of fibroblast growth factor 23 and hypophosphatemia following kidney transplantation.
Pediatric transplantation.
2010
Information Resource
GET IT
Times cited: 23 -
FGF-23: More than a regulator of renal phosphate handling?.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
2010
Academic Article
GET IT
Times cited: 145 -
FGF23: fashion or physiology?.
Clinical journal of the American Society of Nephrology : CJASN.
2010
Editorial Article
GET IT
Times cited: 4 -
Low socioeconomic status associates with higher serum phosphate irrespective of race.
Journal of the American Society of Nephrology : JASN.
2010
Academic Article
GET IT
Times cited: 99 -
Vitamin D deficiency, inflammation, and albuminuria in chronic kidney disease: complex interactions.
Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation.
2010
Academic Article
GET IT
Times cited: 77 -
Pilot study of dietary phosphorus restriction and phosphorus binders to target fibroblast growth factor 23 in patients with chronic kidney disease.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
2010
Academic Article
GET IT
Times cited: 156 -
Recent advances in the rapidly evolving field of fibroblast growth factor 23 in chronic kidney disease.
Current opinion in nephrology and hypertension.
2010
Information Resource
GET IT
Times cited: 30 -
Dietary phosphorus restriction in advanced chronic kidney disease: merits, challenges, and emerging strategies.
Seminars in dialysis.
2010
Information Resource
GET IT
Times cited: 40 -
Common genetic determinants of vitamin D insufficiency: a genome-wide association study.
Lancet (London, England).
2010
Article
GET IT
Times cited: 1425 -
Racial differences in postprandial mineral ion handling in health and in chronic kidney disease.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
2010
Academic Article
GET IT
Times cited: 40 -
Forging forward with 10 burning questions on FGF23 in kidney disease.
Journal of the American Society of Nephrology : JASN.
2010
Information Resource
GET IT
Times cited: 271 -
Impact of poverty on serum phosphate concentrations in the Third National Health and Nutrition Examination Survey.
Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation.
2010
Academic Article
GET IT
Times cited: 37 -
Randomized evaluation of efficacy and safety of ferric carboxymaltose in patients with iron deficiency anaemia and impaired renal function (REPAIR-IDA): rationale and study design.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
2010
Academic Article
GET IT
Times cited: 19 -
Diagnosis and management of mineral metabolism in CKD.
Journal of general internal medicine.
2010
Academic Article
GET IT
Times cited: 19 -
Vitamin D deficiency and anemia in early chronic kidney disease.
Kidney international.
2010
Academic Article
GET IT
Times cited: 121 -
Elevated FGF-23 in a patient with rhabdomyolysis-induced acute kidney injury.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
2009
Article
GET IT
Times cited: 31 -
Second chances in mineral metabolism.
Clinical journal of the American Society of Nephrology : CJASN.
2009
Editorial Article
GET IT
Times cited: 2 -
Circulating fibroblast growth factor 23 in patients with end-stage renal disease treated by peritoneal dialysis is intact and biologically active.
The Journal of clinical endocrinology and metabolism.
2009
Academic Article
GET IT
Times cited: 208 -
Fibroblast growth factor 23 and the future of phosphorus management.
Current opinion in nephrology and hypertension.
2009
Information Resource
GET IT
Times cited: 47 -
Klotho variants and chronic hemodialysis mortality.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
2009
Academic Article
GET IT
Times cited: 58 -
Adiposity, cardiometabolic risk, and vitamin D status: the Framingham Heart Study.
Diabetes.
2009
Academic Article
GET IT
Times cited: 465 -
Integrating research training into residency: tools of human investigation.
Academic medicine : journal of the Association of American Medical Colleges.
2009
Academic Article
GET IT
Times cited: 15 -
Chronic kidney disease, hypovitaminosis D, and mortality in the United States.
Kidney international.
2009
Academic Article
GET IT
Times cited: 200 -
A blueprint for randomized trials targeting phosphorus metabolism in chronic kidney disease.
Kidney international.
2009
Information Resource
GET IT
Times cited: 100 -
Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease.
Circulation.
2009
Academic Article
GET IT
Times cited: 762 -
Plasma gelsolin and circulating actin correlate with hemodialysis mortality.
Journal of the American Society of Nephrology : JASN.
2009
Academic Article
GET IT
Times cited: 105 -
Phosphorus binders and survival on hemodialysis.
Journal of the American Society of Nephrology : JASN.
2008
Academic Article
GET IT
Times cited: 336 -
Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis.
The New England journal of medicine.
2008
Academic Article
GET IT
Times cited: 1570 -
Active vitamin D and survival.
Journal of the American Society of Nephrology : JASN.
2008
Editorial Article
GET IT
Times cited: 9 -
N-terminal pro-B-type natriuretic peptide (NT-proBNP) concentrations in hemodialysis patients: prognostic value of baseline and follow-up measurements.
Clinical chemistry.
2008
Academic Article
GET IT
Times cited: 37 -
Calciphylaxis from nonuremic causes: a systematic review.
Clinical journal of the American Society of Nephrology : CJASN.
2008
Information Resource
GET IT
Times cited: 361 -
Impact of activated vitamin D and race on survival among hemodialysis patients.
Journal of the American Society of Nephrology : JASN.
2008
Academic Article
GET IT
Times cited: 163 -
Prevalence and severity of disordered mineral metabolism in Blacks with chronic kidney disease.
Kidney international.
2008
Academic Article
GET IT
Times cited: 69 -
Renal metastases.
Kidney international.
2008
Article
GET IT
Times cited: 3 -
Postprandial mineral metabolism and secondary hyperparathyroidism in early CKD.
Journal of the American Society of Nephrology : JASN.
2008
Academic Article
GET IT
Times cited: 150 -
Vitamin D deficiency and risk of cardiovascular disease.
Circulation.
2008
Academic Article
GET IT
Times cited: 2140 -
Vitamin D levels and early mortality among incident hemodialysis patients.
Kidney international.
2007
Academic Article
GET IT
Times cited: 744 -
First-trimester placental protein 13 screening for preeclampsia and intrauterine growth restriction.
American journal of obstetrics and gynecology.
2007
Academic Article
GET IT
Times cited: 188 -
Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the United States: data from the Third National Health and Nutrition Examination Survey.
Archives of internal medicine.
2007
Academic Article
GET IT
Times cited: 770 -
Predicting gestational diabetes: choosing the optimal early serum marker.
American journal of obstetrics and gynecology.
2007
Academic Article
GET IT
Times cited: 99 -
Agonistic angiotensin II type 1 receptor autoantibodies in postpartum women with a history of preeclampsia.
Hypertension (Dallas, Tex. : 1979).
2007
Academic Article
GET IT
Times cited: 130 -
Vitamin D in patients with renal failure: a summary of observational mortality studies and steps moving forward.
The Journal of steroid biochemistry and molecular biology.
2007
Information Resource
GET IT
Times cited: 41 -
Vitamin D in patients with kidney disease: cautiously optimistic.
Advances in chronic kidney disease.
2007
Information Resource
GET IT
Times cited: 18 -
Post-transplant hypophosphatemia: Tertiary 'Hyper-Phosphatoninism'?.
Kidney international.
2006
Academic Article
GET IT
Times cited: 183 -
Clinical problem-solving. Needle in a haystack.
The New England journal of medicine.
2006
Article
GET IT
Times cited: 11 -
Postpartum diabetes screening in women with a history of gestational diabetes.
Obstetrics and gynecology.
2005
Academic Article
GET IT
Times cited: 126 -
Case records of the Massachusetts General Hospital. Case 28-2005. A 42-year-old man with weight loss, weakness, and a rash.
The New England journal of medicine.
2005
Article
GET IT
Times cited: 5 -
Circulating levels of the antiangiogenic marker sFLT-1 are increased in first versus second pregnancies.
American journal of obstetrics and gynecology.
2005
Academic Article
GET IT
Times cited: 108 -
Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease.
Journal of the American Society of Nephrology : JASN.
2005
Academic Article
GET IT
Times cited: 812 -
Early pregnancy insulin resistance and subsequent gestational diabetes mellitus.
Diabetes care.
2005
Academic Article
GET IT
Times cited: 39 -
Activated injectable vitamin D and hemodialysis survival: a historical cohort study.
Journal of the American Society of Nephrology : JASN.
2005
Academic Article
GET IT
Times cited: 787 -
Beyond minerals and parathyroid hormone: role of active vitamin D in end-stage renal disease.
Seminars in dialysis.
2005
Information Resource
GET IT
Times cited: 24 -
Preeclampsia and future cardiovascular disease: potential role of altered angiogenesis and insulin resistance.
The Journal of clinical endocrinology and metabolism.
2004
Academic Article
GET IT
Times cited: 199 -
Differential risk of hypertensive disorders of pregnancy among Hispanic women.
Journal of the American Society of Nephrology : JASN.
2004
Academic Article
GET IT
Times cited: 70 -
Insulin resistance and alterations in angiogenesis: additive insults that may lead to preeclampsia.
Hypertension (Dallas, Tex. : 1979).
2004
Academic Article
GET IT
Times cited: 97 -
First trimester placental growth factor and soluble fms-like tyrosine kinase 1 and risk for preeclampsia.
The Journal of clinical endocrinology and metabolism.
2004
Academic Article
GET IT
Times cited: 417 -
Inflammation and glucose intolerance: a prospective study of gestational diabetes mellitus.
Diabetes care.
2004
Academic Article
GET IT
Times cited: 142 -
Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy.
The New England journal of medicine.
2003
Academic Article
GET IT
Times cited: 942 -
First-trimester sex hormone binding globulin and subsequent gestational diabetes mellitus.
American journal of obstetrics and gynecology.
2003
Academic Article
GET IT
Times cited: 100 -
First-trimester C-reactive protein and subsequent gestational diabetes.
Diabetes care.
2003
Academic Article
GET IT
Times cited: 209 -
Insulin resistance but not inflammation is associated with gestational hypertension.
Hypertension (Dallas, Tex. : 1979).
2002
Academic Article
GET IT
Times cited: 54 -
Clinical research career development: the individual perspective.
Academic medicine : journal of the Association of American Medical Colleges.
2002
Academic Article
GET IT
Times cited: 26 -
First trimester insulin resistance and subsequent preeclampsia: a prospective study.
The Journal of clinical endocrinology and metabolism.
2002
Academic Article
GET IT
Times cited: 205 -
Patients with Fabry disease on dialysis in the United States.
Kidney international.
2002
Academic Article
GET IT
Times cited: 197